Publikationen (74) Publikationen von Sebastián Mas Fontao

2024

  1. Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 5

  2. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. A Pilot Study: The Reduction in Fecal Acetate in Obese Patients after Probiotic Administration and Percutaneous Electrical Neurostimulation

    Nutrients, Vol. 15, Núm. 5

  2. A Sarcopenia Index Derived from Malnutrition Parameters in Elderly Haemodialysis Patients

    Nutrients, Vol. 15, Núm. 5

  3. Alpha-klotho and peritoneal membrane status: A hypothesis generating study

    European Journal of Clinical Investigation, Vol. 53, Núm. 3

  4. Fibrosis of Peritoneal Membrane, Molecular Indicators of Aging and Frailty Unveil Vulnerable Patients in Long-Term Peritoneal Dialysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  5. Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  6. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 5

2022

  1. Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients

    Clinical Kidney Journal, Vol. 15, Núm. 8, pp. 1514-1523

  2. Increased 1-year mortality in haemodialysis patients with COVID-19: A prospective, observational study

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 432-441

  3. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

    Frontiers in Pharmacology, Vol. 13

  4. Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  5. One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

    The American Journal of Clinical Nutrition, Vol. 116, Núm. 6, pp. 1565-1579

  6. Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

    European Journal of Nutrition, Vol. 61, Núm. 6, pp. 3095-3108

  7. Sarcopenia and Mortality in Older Hemodialysis Patients

    Nutrients, Vol. 14, Núm. 11

  8. Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations

    PLoS ONE, Vol. 17, Núm. 1 January

2021

  1. Bisphenol S is a haemodialysis-associated xenobiotic that is less toxic than bisphenol A

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1147-1155

  2. Bisphenol a modulates autophagy and exacerbates chronic kidney damage in mice

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

  3. Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients

    Kidney and Blood Pressure Research, Vol. 46, Núm. 1, pp. 126-134

  4. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

    Clinical Nutrition, Vol. 40, Núm. 5, pp. 2825-2836